Showing results (71-80 of 170) with videos related to
Sort By:
Pageof 17
International Urology and Nephrology|January 1, 1987
Prostatic cancer protruding into the bladder imaged by transurethral and transrectal ultrasoundJ O Salo, T Lehtonen, S RannikkoThe Journal of Hospital Infection|February 1, 1989
Septic complications in relation to factors influencing the gastric microflora in patients undergoing gastric surgeryS Sjöstedt, P Levin, A S Malmborg, et al.International Urology and Nephrology|January 1, 1990
Efficacy of orchiectomy versus high dose polyoestradiol phosphate (160 mg) in relieving infravesical obstruction in patients with prostatic cancerJ Aro, R Haapiainen, S Rannikko, et al.Journal of Steroid Biochemistry|June 1, 1989
Steroid sulfates in testis tissue of prostatic cancer patients treated for six months with the gonadotropin releasing hormone agonist buserelinI Huhtaniemi, S Rannikko, M Orava, et al.Journal of Andrology|November 1, 1987
Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. II. Endocrinology and histology of the testisI Huhtaniemi, H Nikula, M Parvinen, et al.American Journal of Clinical Oncology|January 1, 1988
Histological and functional changes of the testis tissue during GnRH agonist treatment of prostatic cancerI Huhtaniemi, H Nikula, M Parvinen, et al.Infection|July 1, 1994
Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient populationF Karpati, A S Malmborg, H Alfredsson, et al.Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1982
Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapyB Brismar, C Hårdstedt, S Jacobson, et al.Clinical Science (London, England : 1979)|October 1, 1990
Renal function in rats with essential fatty acid deficiencyL Hjelte, M Larsson, A Alvestrand, et al.International Journal of Andrology|October 1, 1991
Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effectsI Huhtaniemi, M Parvinen, P Venho, et al.Pageof 17